Pharmaceutical

AstraZeneca scores its second paediatric approval for Soliris in Japan

Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.

Aug 26, 2023 - 20:00
AstraZeneca scores its second paediatric approval for Soliris in Japan
Soliris is already approved to treat refractory generalised myasthenia gravis in adults in different regions.
Read the original article

Tags:

Previous Article

Microbiome company Enterome plans $108m raise to fund Phase II cancer trials

Next Article

Wegovy can reduce heart failure symptoms in obese patients, study shows

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BMS licenses TCR-T immunotherapy therapy from Immatics

BMS licenses TCR-T immunotherapy therapy from Immatics

May 2, 2023

U.S. pregnancy deaths dropped in 2022, after Covid spike

U.S. pregnancy deaths dropped in 2022, after Covid spike

Mar 19, 2023

Novartis acquires Mariana in $1.75bn deal to strengthen radioligand portfolio 

Novartis acquires Mariana in $1.75bn deal to strengthen...

May 3, 2024